Mitsubishi Tanabe Pharma America

Mitsubishi Tanabe Pharma America (MTPA) is a pharmaceutical company focused on developing and commercializing innovative therapies for patients with serious diseases. A subsidiary of Mitsubishi Tanabe Pharma Corporation, MTPA leverages its parent company's extensive research and development capabilities to bring novel treatments to the U.S. market. The company generates revenue through the sale of its pharmaceutical products, particularly in the areas of neurology and rare diseases. Founded in 2007, MTPA has a significant presence in the biopharmaceutical industry, known for its commitment to improving patient outcomes through advanced medical solutions.

Recent Posts by Mitsubishi Tanabe Pharma America

1-18 of 18